Financhill
Back

Editas Medicine, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Sell
36

EDIT
Editas Medicine, Inc.

Last Price:
$2.52
Seasonality Move:
-5.13%
Sell
44

RAPT
Rapt Therapeutics, Inc.

Last Price:
$34.00
Seasonality Move:
-10.23%
Sell
36
Editas Medicine, Inc. (EDIT) is a Sell

Is Editas Medicine, Inc. a Buy, Sell or Hold?

  • The current Editas Medicine, Inc. [EDIT] share price is $2.51. The Score for EDIT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Rapt Therapeutics, Inc. [RAPT] share price is $34.03. The Score for RAPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine, Inc.'s stock price today?

  • The Editas Medicine, Inc. share price today is $2.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

  • The Rapt Therapeutics, Inc. share price today is $34.03
    The current trend is moderately bullish and RAPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 47.22 Sell
Chaikin Money Flow: 84316 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.34 - 2.6) Buy
Bollinger Bands (100): (2.37 - 3.41) Sell

RAPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.66 Buy
Relative Strength Index (14 RSI): 55.95 Buy
Chaikin Money Flow: 205819 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.63 - 34.75) Buy
Bollinger Bands (100): (14.04 - 31.9) Buy

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.49 Buy
20-day SMA: 2.44 Buy
50-day SMA: 2.95 Sell
200-day SMA: 2.36 Buy
8-day EMA: 2.48 Buy
20-day EMA: 2.5 Buy
50-day EMA: 2.4 Buy
200-day EMA: 1.22 Buy

RAPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.08 Sell
20-day SMA: 32.41 Buy
50-day SMA: 30.48 Buy
200-day SMA: 15.73 Buy
8-day EMA: 34.48 Sell
20-day EMA: 33.02 Buy
50-day EMA: 29.7 Buy
200-day EMA: 21.78 Buy

Editas Medicine, Inc. Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.89 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.75 per share, and a decrease next year of $0.91 per share.

Editas Medicine, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):